ZEB1 and cancer: The ZEB1/miR-200 axis likely has additional, non-cell autonomous roles in cancer pathogenesis, as it has recently been shown to affect immune recognition of cancer cells whereby ZEB1 suppression of the miR-200 family leads to upregulation of PD-L1, a direct miR-200 family target.